quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:49:00·750d
NEWSRelease
Eiger BioPharmaceuticals Inc. logo

Eiger Biopharmaceuticals Says On April 2, Received Notice From Nasdaq That Co's Common Stock Will Be Delisted From Nasdaq; Common Stock Is Expected To Begin Trading On Over-Counter Market On April 11

EIGR· Eiger BioPharmaceuticals Inc.
Health Care
Original source

Companies

  • EIGR
    Eiger BioPharmaceuticals Inc.
    Health Care

Recent analyst ratings

  • Aug 9UpdateCitigroup$27.00

Related

  • 13D/G713d
    SEC Form SC 13G/A filed by Eiger BioPharmaceuticals Inc. (Amendment)
  • SEC715d
    SEC Form 8-K filed by Eiger BioPharmaceuticals Inc.
  • SEC721d
    SEC Form 8-K filed by Eiger BioPharmaceuticals Inc.
  • SEC724d
    SEC Form 10-K/A filed by Eiger BioPharmaceuticals Inc. (Amendment)
  • SEC745d
    SEC Form 10-K filed by Eiger BioPharmaceuticals Inc.
  • NEWS749d
    12 Health Care Stocks Moving In Thursday's After-Market Session
  • NEWS749d
    Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
  • NEWS749d
    12 Health Care Stocks Moving In Thursday's Intraday Session
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022